APMA News - November/December 2012 - (Page 66)

IT Consultant By James R. Christina, DPM Stage 2 of Meaningful Use—What Are the Changes? CMS has released the final rule for Stage 2 of Meaningful Use. This article summarizes some of the major features of Stage 2 to help you prepare for the 2014 effective date. Note that some measures of the final rule also affect Stage 1 requirements. Starting in 2014, providers who have met Stage 1 requirements for two or three years will have to meet Meaningful Use Stage 2 criteria. Stage 2 includes new objectives to improve patient care through better clinical decision support, care coordination, and patient engagement. In Stage 1, participating providers were obligated to report 15 core objectives and five out of 10 menu-set objectives. In Stage 2, 20 objectives remain, between the core and menu-set objectives. In Stage 2, providers must report on 17 core objectives and three out of six menu-set objectives. In Stage 2, some menu-set objectives have been changed to core objectives, and the requirements to achieve the objectives have increased. For example, the core objective to record demographics goes from a 50-percent requirement in Stage 1 to an 80-percent requirement in Stage 2. In Stage 1, the requirement to generate a patient list by a specific condition was a menu-set requirement. That is now a core objective in Stage 2. There are changes to Stage 1, as well. A few become effective in 2013, but most are optional for 2013 and effective in 2014. Effective in 2013: One test of electronic transmission of key clinical information is no longer required, and the phrase “except where prohibited” has been added to immunization, reportable labs, and syndromic surveillance. Optional in 2013 but required in 2014: Computerized physician order entry is the number of orders during the EHR reporting period; change in age limit from two to three for blood pressure; no age limit for height and weight; blood pressure can be separately excluded from height and weight if not relevant to scope of practice. Physicians also must provide patients the ability to view online, download, and transmit their health information. Providers must report on nine of the 64 clinical quality measures representing at least three of the six domains listed at the bottom of the first column. Finally, and most importantly, because these changes apply to all stages of Meaningful Use reporting, starting in 2014, all EHR incentive program participants will be required to adopt certified EHR technology that meets the Office of the National Coordinator’s Standards and Certification Criteria 2014 final rule. Providers currently using a certified EHR to report meaningful use must ensure their EHR vendor goes through the certification process to meet the 2014 certification criteria and that they use that EHR beginning in 2014. Because the change to Stage 2 may represent a challenge to participating providers, all reporting in 2014 will be for a 90-day reporting period regardless of your prior Meaningful Use reporting participation or what stage you are reporting. More information on Stage 2 Meaningful Use requirements can be found at www.cms.gov/Regulations-and-Guid ance/Legislation/EHRIncentivePrograms/Stage_2.html and www.cms.gov/Regulations-and-Guidance/Legislation/EHR IncentivePrograms/Downloads/Stage2Overview_Tipsheet. pdf, as well as on APMA.org. Visit www.apma.org and click on Education & Professional Development, Webinars, then select the archive of past webinars to view a Stage 2 Meaningful Use webinar. n Summary of Meaningful Use Payment and Stages Maximum Payment by Start Year 2011 $44,000 2012 $44,000 2013 $39,000 2014 $24,000 • • Annual Incentive Payment by Stage of Meaningful Use 2011 1 $18,000 2012 1 $12,000 1 $18,000 2013 1 $8,000 1 $12,000 1 2014 2 $4,000 2 $8,000 1 $13,000 1 $12,000 2015 2 $2,000 2 $4,000 2 $8,000 1 $8,000 3 $2,000 2 $4,000 2 $4,000 2016 3 There will be changes to clinical quality measures reporting in 2014, as well. No longer an objective for meaningful use, reporting of clinical quality measures will be required to achieve meaningful use. In 2014, clinical quality measures reported must represent measures from at least three of the six HHS National Quality Strategy Domains: Patient and Family Engagement Patient Safety Care Coordination Population and Public Health Efficient Use of Health-Care Resources Clinical Processes/Effectiveness • • • • • • Contact Dr. Christina at jrchristina@apma.org. 66 APMA News November/December 2012 http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Stage_2.html http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Stage_2.html http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Downloads/Stage2Overview_Tipsheet.pdf http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Downloads/Stage2Overview_Tipsheet.pdf http://www.APMA.org http://www.apma.org

Table of Contents for the Digital Edition of APMA News - November/December 2012

APMA News - November/December 2012
President’s Message
Contents
United States of Diabetes
Corporate Partners and Members: A History of Generosity
Tradition of Leadership: APMA Executive Directors Move Podiatric Medicine Forward
100 Years of Chiropody History in the UK: A Personal View
Annual Scientifi c Meeting Registration Form
2012 Podiatric Practice Survey: Age and Gender by Practice Arrangement Type
APMA By the Decade: 2002–2012
Reimbursement
Federal Advocacy Forum
Cosponsors to the Equity and Access for Podiatric Physicians Under Medicaid Act
APMAPAC Contributions in the 2011–12 Election Year
APMAPAC Chair Report
IT Consultant
Website Wisdom
Technofi
Small Business 101
CPME Update
APMA All Stars
Resolutions Deadlines
In Short
Worthy of Note
Affi liates Corner
Insurance Advisor
New Members
Death Notices
APMAPAC Update
Classified Advertising
Dates to Remember
Advertising Index
10 Questions
Your APMA

APMA News - November/December 2012